Clinical Trial Update: The RETRAIN Trial Phase 2 [NA]

View source ↗

Summary

The RETRAIN Trial Phase 2, sponsored by Firstkind Ltd, is currently recruiting participants for an ischemic stroke study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Snippet

Sponsor: Firstkind Ltd | Conditions: Ischaemic Stroke | NA | Status: RECRUITING